Articles

Podcasts

Videos

Infectious Disease

Infectious Disease condition center page is a comprehensive resource for clinical news and insights on viruses, infections, and bacteria. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for COVID-19, influenza, vaccine-preventable diseases, and more.

The adverse event rate was 2.2% for patients with IBD following 1 dose of the vaccine.

COVID-19 Vaccination Safe and Effective for IBD Patients

There was an adequate response for pediatric patients on biologics to the H1N1 and H3N2 serotypes.

More Research Needed on Efficacy of Vaccinations for Pediatric Patients on Biologics

The guidelines replace risk-based reccomendations for adults between 19-59 years.


CDC Recommends Universal Hepatitis B Vaccinations for Adults

Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.

Bayesian Network Models can Accurately Predict Risk of Guillain-Barré Syndrome

Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older. 

Doctor Knowledge Lacking in Prescribing Pneumococcal Vaccinations for Patients With Cardiovascular Disease

As influenza A(H3N2) remains the most prevalent subtype in the US, investigators estimated the available flu shot is not significantly preventing positive cases.

2021-22 Flu Vaccine Less Effective Against Current Virus

An executive with Seqirus discusses the company's work to address age-related flu severity risks.

Critical Needs in Influenza: Better Options, Improving Hesitancy

A look into the research and prospects Seqirus looks to fulfill with the technology platofrm.

Delivering mRNA Technology to Flu Vaccination

A new study suggests even the phrasing of telemedicine notifications may make a difference in vaccine uptake.

 Flu Shot Reservation Text Messaging May Improve Vaccination Rates

An Israel cohort analysis suggests a "hybrid" of natural and vaccine-induced immunity is associated with the rare likelihood of SARS-CoV-2 reinfection.

Single Dose of Pfizer-BioNTech COVID-19 Vaccine Linked to 82% Reduced Reinfection Risk

On the HCPLive vaccination page, resources on the topics of medical news and expert insight into preventive medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on immunization, and more.

Vaccination

Latest News